课题基金 / 基金详情

项目摘要

项目成果

CYNTHIA A LEMERE的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Active Abeta Immunization: Abeta immunotherapy has potential for preventing and possibly treating Alzheimer's disease (AD) in humans. Studies in genetically-engineered AD mouse models have consistently demonstrated efficacy of the Abeta vaccine both in lowering CNS Abeta and improving cognition without any adverse effects. However, the first human clinical trial was halted due to meningoencephalitis in approximately 6% of patients; recognition of the full-length Abeta immunogen as a self-protein may have attributed to these adverse events. Non-human primates, including Caribbean vervets (Chlorocebus aethiops), have the same amyloid precursor protein (APP) and Abeta as humans, and have age-related cerebral plaque deposition. Thus, they may serve as a better animal model for studying Abeta clearance and immune responses to Abeta vaccination. We have trained vervets for behavioral testing of cognitive functions and began Abeta vaccination in June 2006. Our goals are to characterize the humoral and cellular immune responses to a novel Abeta vaccine and to determine the vaccine's efficacy in lowering Abeta within the nervous system and improving cognition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation of a Complement C3 Conditional Knockout Mouse
  • 批准号:
    8741912
  • 项目类别:
  • 资助金额:
    $20.71万
  • 财政年份:
    2013
  • 负责人:
    CYNTHIA A LEMERE
  • 依托单位:
Generation of a Complement C3 Conditional Knockout Mouse
  • 批准号:
    8638529
  • 项目类别:
  • 资助金额:
    $26.82万
  • 财政年份:
    2013
  • 负责人:
    CYNTHIA A LEMERE
  • 依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
  • 批准号:
    8371341
  • 项目类别:
  • 资助金额:
    $33.7万
  • 财政年份:
    2012
  • 负责人:
    CYNTHIA A LEMERE
  • 依托单位:
Pyroglutamate Amyloid-beta as an Immunotherapeutic Target for Alzheimer's Disease
  • 批准号:
    8702980
  • 项目类别:
  • 资助金额:
    $33.89万
  • 财政年份:
    2012
  • 负责人:
    CYNTHIA A LEMERE
  • 依托单位:
海外基金